Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr:115:106790.
doi: 10.1016/j.addbeh.2020.106790. Epub 2020 Dec 30.

Association of dual and poly tobacco use with depressive symptoms and use of antidepressants

Onyema Greg Chido-Amajuoyi  1 , Dale S Mantey  2 , Onyinye Omega-Njemnobi  3 , Robert K Yu  4 , Sanjay Shete  5
Affiliations

Association of dual and poly tobacco use with depressive symptoms and use of antidepressants

Onyema Greg Chido-Amajuoyi et al. Addict Behav. 2021 Apr.

Abstract

Background: There is an established link between depression and tobacco use among adults; however, to date, research has not explored the association of use of dual/poly tobacco products with symptoms and use of medication for depression.

Methods: Data were derived from a 2018 Texas population health assessment survey (n = 2034). Multivariable logistic and multinomial regressions were used to examine for associations between self-reported symptoms of depression and use of prescription medications for depression with use of dual/poly tobacco products.

Results: About 20% of adults used one tobacco product, while 9.7% used two or more products. Compared to those without depressive symptoms, those with depressive symptoms had greater odds of single (aOR: 1.66, 95% CI; 1.21 - 2.29) or dual/poly (aOR: 3.09, 95% CI; 1.92 - 4.96) tobacco product use relative to non-users; and relative to single product use, those with depressive symptoms had greater odds of dual/poly tobacco product use (aOR: 2.07; 95% CI, 1.30 - 3.32). Compared to those not using medication for depression, use of medication for depression was associated with a 1.80 (95% CI: 1.15 - 2.84) greater odds of dual/poly tobacco product use relative to non-users; and a 1.91 (95% CI: 1.14 - 3.19) greater odds of dual/poly product use relative to single product users.

Conclusions: Study findings call for primary care providers and psychiatrists to expand screening of individuals experiencing depressive symptoms and using medication for depression, to include assessment for dual/poly tobacco product use.

Keywords: Anti-depressants; Cigarette; Depression; E-cigarette; Poly tobacco; Tobacco.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

References

    1. Angst J, & Merikangas K (1997). The depressive spectrum: diagnostic classification and course. Journal of affective disorders, 45(1–2), 31–40. - PubMed
    1. Bandiera FC, Loukas A, Li X, Wilkinson AV, & Perry CL (2017). Depressive symptoms predict current e-cigarette use among college students in texas. nicotine & tobacco research, 19(9), 1102–1106. - PMC - PubMed
    1. Bandiera FC, Loukas A, Wilkinson AV, & Perry CL (2016). Associations between tobacco and nicotine product use and depressive symptoms among college students in Texas. Addictive behaviors, 63, 19–22. - PMC - PubMed
    1. Blake KD, Ciolino HP, & Croyle RT (2019). Population health assessment in NCI-designated cancer center catchment areas: AACR. - PubMed
    1. Bliden KP, DiChiara J, Lawal L, Singla A, Antonino MJ, Baker BA, … Gurbel PA (2008). The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. Journal of the American College of Cardiology, 52(7), 531–533. - PubMed

Publication types

Substances